Archive for the ‘Amylin Pharmaceuticals Inc’ Category

Amylin Pharmaceuticals

February 7th, 2012 | Posted in 2012, Amylin Pharmaceuticals Inc

Amylin Pharmaceuticals – Received FDA approval for its once-a-week diabetes injection Bydureon, which is a longer-lasting version of Amylin’s drug, Byretta, which is taken twice a day.  The drug wil be available nationwide in February, 2012.

Amylin Pharmaceuticals

October 20th, 2011 | Posted in 2011, Amylin Pharmaceuticals Inc

Amylin Pharmaceuticals – San Diego:  Has received approval from the United Kingdom’s health-cost agency for use in combination with two glucose-lowering medicines their Bydureon drug, a long-lasting diabetics drug that Amylin developed. It will be co-marketed with Eli Lilly.

Amylin Pharmaceuticals Inc

June 22nd, 2011 | Posted in 2011, Amylin Pharmaceuticals Inc

Amylin Pharmaceuticals Inc. – San Diego:  Recieved word Tuesday when the European EU drug regulatorsapproved Amylin’s Type-2 Diabetes medication, Bydureon.  Shares of Amylin rose 40-cents, or more than 3%, based on the news!